Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Cell-Free DNA (cf-DNA) Testing Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Cell-Free DNA (cf-DNA) Testing Market Status and Forecast (2016-2027)
      • 1.3.2 Global Cell-Free DNA (cf-DNA) Testing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Cell-Free DNA (cf-DNA) Testing Supply by Company

    • 2.1 Global Cell-Free DNA (cf-DNA) Testing Sales Value by Company
    • 2.2 Cell-Free DNA (cf-DNA) Testing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Cell-Free DNA (cf-DNA) Testing Market Status by Category

    • 3.1 Cell-Free DNA (cf-DNA) Testing Category Introduction
      • 3.1.1 Donor-derived
      • 3.1.2 Circulating
      • 3.1.3 Cell-free
    • 3.2 Global Cell-Free DNA (cf-DNA) Testing Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Cell-Free DNA (cf-DNA) Testing Market Status by End User/Segment

    • 4.1 Cell-Free DNA (cf-DNA) Testing Segment by End User/Segment
      • 4.1.1 Oncology
      • 4.1.2 Gynecology
      • 4.1.3 Transplantation
    • 4.2 Global Cell-Free DNA (cf-DNA) Testing Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Cell-Free DNA (cf-DNA) Testing Market Status by Region

    • 5.1 Global Cell-Free DNA (cf-DNA) Testing Market by Region
    • 5.2 North America Cell-Free DNA (cf-DNA) Testing Market Status
    • 5.3 Europe Cell-Free DNA (cf-DNA) Testing Market Status
    • 5.4 Asia Pacific Cell-Free DNA (cf-DNA) Testing Market Status
    • 5.5 Central & South America Cell-Free DNA (cf-DNA) Testing Market Status
    • 5.6 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Status

    6 North America Cell-Free DNA (cf-DNA) Testing Market Status

    • 6.1 North America Cell-Free DNA (cf-DNA) Testing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Cell-Free DNA (cf-DNA) Testing Market Status

    • 7.1 Europe Cell-Free DNA (cf-DNA) Testing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Cell-Free DNA (cf-DNA) Testing Market Status

    • 8.1 Asia Pacific Cell-Free DNA (cf-DNA) Testing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Cell-Free DNA (cf-DNA) Testing Market Status

    • 9.1 Central & South America Cell-Free DNA (cf-DNA) Testing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Status

    • 10.1 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Cell-Free DNA (cf-DNA) Testing Market Forecast by Category and by End User/Segment

    • 12.1 Global Cell-Free DNA (cf-DNA) Testing Sales Value Forecast (2022-2027)
    • 12.2 Global Cell-Free DNA (cf-DNA) Testing Forecast by Category
    • 12.3 Global Cell-Free DNA (cf-DNA) Testing Forecast by End User/Segment

    13 Global Cell-Free DNA (cf-DNA) Testing Market Forecast by Region/Country

    • 13.1 Global Cell-Free DNA (cf-DNA) Testing Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Trovagene
      • 14.1.1 Company Information
      • 14.1.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.1.3 Trovagene Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sequenom
      • 14.2.1 Company Information
      • 14.2.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.2.3 Sequenom Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Roche
      • 14.3.1 Company Information
      • 14.3.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.3.3 Roche Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Quest Diagnostics
      • 14.4.1 Company Information
      • 14.4.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.4.3 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Natera
      • 14.5.1 Company Information
      • 14.5.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.5.3 Natera Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Invited
      • 14.6.1 Company Information
      • 14.6.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.6.3 Invited Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Illumania
      • 14.7.1 Company Information
      • 14.7.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.7.3 Illumania Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Guardant Health
      • 14.8.1 Company Information
      • 14.8.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.8.3 Guardant Health Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 CareDx
      • 14.9.1 Company Information
      • 14.9.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.9.3 CareDx Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Biodesix
      • 14.10.1 Company Information
      • 14.10.2 Cell-Free DNA (cf-DNA) Testing Product Introduction
      • 14.10.3 Biodesix Cell-Free DNA (cf-DNA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Biocept
    • 14.12 Allenex
    • 14.13 Agilent Technology

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Cell-Free DNA (cf-DNA) Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Cell-Free DNA (cf-DNA) Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Donor-derived
      Circulating
      Cell-free

      Segmented by End User/Segment
      Oncology
      Gynecology
      Transplantation

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Trovagene
      Sequenom
      Roche
      Quest Diagnostics
      Natera
      Invited
      Illumania
      Guardant Health
      CareDx
      Biodesix
      Biocept
      Allenex
      Agilent Technology
      Buy now